Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

被引:11
|
作者
Burns, Madeleine D. [1 ]
Boribong, Brittany P. [1 ]
Bartsch, Yannic C. [2 ]
Loiselle, Maggie [1 ]
St Denis, Kerri J. [2 ]
Sheehan, Maegan L. [2 ]
Chen, Jessica W. [2 ]
Davis, Jameson P. [1 ]
Lima, Rosiane [1 ]
Edlow, Andrea G. [3 ]
Fasano, Alessio [1 ]
Balazs, Alejandro B. [2 ]
Alter, Galit [2 ]
Yonker, Lael M. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Boston, MA 02114 USA
[2] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[3] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Vincent Ctr Reprod Biol, Boston, MA 02114 USA
关键词
SARS-CoV-2; COVID-19; pediatrics; adolescents; vaccines; boosters; immunology; antibodies; STATES;
D O I
10.3390/vaccines10040492
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls for broader understanding of the adolescent immune profile after mRNA vaccination. We tested the durability and cross-reactivity of anti-SARS-CoV-2 serologic responses over a six-month time course in vaccinated adolescents against the SARS-CoV-2 D614G ("wild type") and Omicron antigens. Serum from 77 adolescents showed that anti-Spike antibodies wane significantly over six months. After completion of a two-vaccine series, cross-reactivity against Omicron-specific receptor-binding domain (RBD) was seen. Functional humoral activation against wild type and Omicron SARS-CoV-2 also declines over time in vaccinated adolescent children. Evidence of waning mRNA-induced vaccine immunity underscores vulnerabilities in long-term pediatric protection against SARS-CoV-2 infection, while cross-reactivity highlights the additional benefits of vaccination. Characterization of adolescent immune signatures post-vaccination will inform guidance on vaccine platforms and timelines, and ultimately optimize immunoprotection of children.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] SARS-CoV-2 cross-reactivity in healthy donors
    van der Heide V.
    Nature Reviews Immunology, 2020, 20 (7) : 408 - 408
  • [2] SARS-CoV-2 serological cross-reactivity with autoantibodies
    Choy, Kay Weng
    LANCET RHEUMATOLOGY, 2021, 3 (01): : E15 - E15
  • [3] Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (15): : 1249 - 1249
  • [4] SARS-CoV-2 serological cross-reactivity with autoantibodies Reply
    Teng, Jialin
    Dai, Jin
    LANCET RHEUMATOLOGY, 2021, 3 (01): : E16 - E16
  • [5] BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity
    Eggenhuizen, Peter J.
    Ng, Boaz H.
    Chang, Janet
    Fell, Ashleigh L.
    Cheong, Rachel M. Y.
    Wong, Wey Y.
    Gan, Poh-Yi
    Holdsworth, Stephen R.
    Ooi, Joshua D.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
    Bates, Timothy A.
    Weinstein, Jules B.
    Farley, Scotland
    Leier, Hans C.
    Messer, William B.
    Tafesse, Fikadu G.
    CELL REPORTS, 2021, 34 (07):
  • [7] Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
    Hicks, Jennifer
    Klumpp-Thomas, Carleen
    Kalish, Heather
    Shunmugavel, Anandakumar
    Mehalko, Jennifer
    Denson, John-Paul
    Snead, Kelly R.
    Drew, Matthew
    Corbett, Kizzmekia S.
    Graham, Barney S.
    Hall, Matthew D.
    Memoli, Matthew J.
    Esposito, Dominic
    Sadtler, Kaitlyn
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (05) : 906 - 913
  • [8] Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
    Jennifer Hicks
    Carleen Klumpp-Thomas
    Heather Kalish
    Anandakumar Shunmugavel
    Jennifer Mehalko
    John-Paul Denson
    Kelly R. Snead
    Matthew Drew
    Kizzmekia S. Corbett
    Barney S. Graham
    Matthew D. Hall
    Matthew J. Memoli
    Dominic Esposito
    Kaitlyn Sadtler
    Journal of Clinical Immunology, 2021, 41 : 906 - 913
  • [9] INADEQUATE SARS-COV-2 ANTIBODY RESPONSE TO MRNA SARS-COV-2 VACCINE IN ADOLESCENT KIDNEY TRANSPLANT RECIPIENTS
    Loop, L.
    Crane, C.
    Anterasian, C.
    Geng, B.
    Ingulli, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S7 - S8
  • [10] Impact of cross-reactivity and herd immunity on SARS-CoV-2 pandemic severity
    Owusu-Boaitey, Nana
    Boettcher, Lucas
    He, Daihai
    Erkhembayar, Ryenchindorj
    Yang, Lin
    Kim, Dong-Hyun
    Barchuk, Anton
    Gorski, David H.
    Howard, Jonathan
    INFECTIOUS DISEASES, 2024, 56 (10) : 897 - 902